Immuneering Corporation (IMRX)
NASDAQ: IMRX
· Real-Time Price · USD
3.79
0.75 (24.67%)
At close: Aug 15, 2025, 3:47 PM
3.79
0.13%
After-hours: Aug 15, 2025, 04:00 PM EDT
Immuneering Fail-to-Deliver
Total FTD Shares
149
Below Average
FTD / Avg. Volume
< 0.01%
Low Impact
1-Year Change
-79.6%
Negative Trend
FTD Chart
As of Jul 9, 2025,
Immuneering Corporation has
149
shares failed to deliver, representing 0.01%
of the average daily volume of
1,265,819
shares. Over the past year, the monthly average FTD is
27,493
shares, with the current level 99% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 09, 2025 | 4.45 | 149 | -96.81% |
| Jun 30, 2025 | 3.37 | 4.67K | +438.52% |
| May 29, 2025 | 1.7 | 867 | -66.87% |
| Apr 29, 2025 | 1.47 | 2.62K | +551.00% |
| Mar 31, 2025 | 1.52 | 402 | -92.89% |
| Feb 28, 2025 | 1.65 | 5.65K | +0.82% |
| Jan 31, 2025 | 1.94 | 5.61K | -57.15% |
| Dec 31, 2024 | 2.2 | 13.09K | +555.71% |
| Nov 26, 2024 | 2.05 | 2K | -28.36% |
| Oct 30, 2024 | 1.92 | 2.79K | -85.24% |
| Sep 30, 2024 | 2.49 | 18.88K | +41851.11% |
| Aug 30, 2024 | 1.11 | 45 | +181.25% |
| Jul 12, 2024 | 1.24 | 16 | -99.62% |
| Jun 27, 2024 | 1.43 | 4.23K | +323.10% |
| May 28, 2024 | 1.44 | 1K | +122.72% |
| Apr 25, 2024 | 1.43 | 449 | -99.00% |
| Mar 28, 2024 | 2.89 | 44.68K | +247.57% |
| Feb 28, 2024 | 6.35 | 12.86K | +321300.00% |
| Jan 31, 2024 | 5.87 | 4 | -93.10% |
| Dec 27, 2023 | 7.4 | 58 | +13.73% |
| Nov 30, 2023 | 6.56 | 51 | -77.92% |
| Oct 30, 2023 | 5.96 | 231 | +220.83% |
| Sep 29, 2023 | 7.68 | 72 | -82.13% |
| Aug 09, 2023 | 10 | 403 | -69.35% |
| Jul 31, 2023 | 10.16 | 1.31K | -55.99% |
| Jun 30, 2023 | 10.14 | 2.99K | +723.14% |
| May 31, 2023 | 7.75 | 363 | +109.83% |
| Apr 25, 2023 | 10.14 | 173 | -95.84% |
| Mar 31, 2023 | 9.71 | 4.16K | +1119.06% |
| Feb 28, 2023 | 4.89 | 341 | -34.67% |
| Jan 23, 2023 | 4.18 | 522 | n/a |